67571-90-8

Basic information

• Product Name: 3-BENZYL-3,8-DIAZABICYCLO[3.2.1]OCTANE
• Synonyms: 3-(PhenylMethyl)-3,8-diazabicyclo[3.2.1]octane;3,8-Diazabicyclo[3.2.1]octane, 3-(phenylMethyl)-
• CAS NO: 67571-90-8
• Molecular Formula: C₁₃H₁₈N₂
• Molecular Weight: 202.299
• EINECS: 249-329-3
• Product Categories: Aromatics;Heterocycles;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals
• Mol File: 67571-90-8.mol

Chemical Properties

• Melting Point: 28-29°C
• Boiling Point: 309.164 °C at 760 mmHg
• Flash Point: 131.436 °C
• Appearance: /
• Density: 1.074±0.06 g/cm3 (20 ºC 760 Torr)
• Vapor Pressure: 7.27E-05mmHg at 25°C
• Refractive Index: 1.584
• PKA: 10.07±0.20(Predicted)
• CAS DataBase Reference: 3-BENZYL-3,8-DIAZABICYCLO[3.2.1]OCTANE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BENZYL-3,8-DIAZABICYCLO[3.2.1]OCTANE(67571-90-8)
• EPA Substance Registry System: 3-BENZYL-3,8-DIAZABICYCLO[3.2.1]OCTANE(67571-90-8)

Safety Data

• Hazard Codes: C:Corrosive
• Statements: R34:
• Safety Statements: S23:; S26:; S36/37/39:; S45:
• Hazardous Substances Data: 67571-90-8(Hazardous Substances Data)

Usage

Uses

A

InChI:InChI=1/C14H17NO/c16-14-8-12-6-7-13(9-14)15(12)10-11-4-2-1-3-5-11/h1-5,12-13H,6-10H2

Upstream product

• 96483-83-9 3-benzyl-3,8-diazabicyclo[3.2.1]octane-2,4-dione 
• 501-53-1 benzyl chloroformate 
• 149771-44-8 8-t-butoxycarbonyl-3,8-diazabicyclo[3.2.1]octane 
• 54221-37-3 diethyl meso-2,5-dibromoadipate 
• 52321-06-9 cis-1-benzylpyrrolidine-2,5-dicarboxylic acid diethyl ester 
• 37061-44-2 3,8-dibenzyl-3,8-diazabicyclo[3.2.1]octane-2,4-dione 
• 17783-46-9 3-benzyl-2,4-dioxo-8-methyl-3,8-diazabicyclo-(3.2.1)octane 
• 1296208-18-8 2,5-bis(((methylsulfonyl)oxy)methyl)pyrrolidine 
• 100-46-9 benzylamine 
• 41994-50-7 diethyl meso-2,5-pyrrolidinedicarboxylate 
• 5626-66-4 2,5-dihydroxymethylpyrrolidine 
• 1384448-78-5 (2R,5S)-ethyl 1-benzyl-5-(benzylcarbamoyl)pyrrolidine-2-carboxylate 
• 149771-43-7 3-benzyl-8-(tert-butoxycarbonyl)-3,8-diazabicyclo[3.2.1]-octane 
• 100-39-0 benzyl bromide 

Downstream Products

• 149771-40-4 N,N'-bis-3-benzyl-8-(3,8-diazabicyclo(3.2.1)octyl)-glutaramide 
• 172207-91-9 (3-benzyl-3,8-diaza-bicyclo[3.2.1]oct-8-yl)-(1H-indol-2-yl)-methanone 
• 223593-83-7 benzofuran-2-yl-(3-benzyl-3,8-diaza-bicyclo[3.2.1]oct-8-yl)-methanone 
• 63978-12-1 3-benzyl-8-propionyl-3,8-diaza-bicyclo[3.2.1]octane 
• 67572-25-2 3-benzyl-8-butyryl-3,8-diaza-bicyclo[3.2.1]octane 
• 401514-13-4 4-[2-(3-benzyl-3,8-diaza-bicyclo[3.2.1]oct-8-yl)-ethoxy]-phenylamine 
• 401514-09-8 (4-amino-phenyl)-(3-benzyl-3,8-diaza-bicyclo[3.2.1]oct-8-yl)-methanone 
• 90673-35-1 3,8-diazabicyclo[3.2.1]octane dihydrochloride 
• 149771-44-8 8-t-butoxycarbonyl-3,8-diazabicyclo[3.2.1]octane 
• 149771-43-7 3-benzyl-8-(tert-butoxycarbonyl)-3,8-diazabicyclo[3.2.1]-octane 
• 845626-29-1 C₁₉H₃₀N₂O₂Si 
• 1120214-83-6 C₂₃H₃₅N₃O₂ 
• 1201633-33-1 3-benzyl-8-pyridin-3-yl-3,8-diazabicyclo[3.2.1]octane 
• 1201632-20-3 1-[4-(4-chloro-3-trifluoromethylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-[8-(5-fluoropyrimidin-2-yl)-3,8-diazabicyclo[3.2.1]oct-3-yl]ethanone 

Relevant articles and documents

Phenyl-diazabicyclo derivative and application thereof

The invention discloses a phenyl-diazabicyclo derivative and application thereof, as well as pharmaceutical compositions containing such compounds, which are used for inhibiting serotonin reuptaking.The invention also relates to methods of preparing such

Pyruvate kinase activators for use in therapy

Described herein are methods for using compounds that activate pyruvate kinase.

An improved and scalable process for 3,8-diazabicyclo[3.2.1]octane analogues

An improved and scalable process for substituted 3,8-diazabicyclo[3.2.1] octane was developed. N-Benzyl-2,5-dicarbethoxy-pyrrolidine 2 was reduced to N-benzyl-2,5-dihydroxymethylpyrrolidine 9 and subsequently debenzylated to afford N-Boc-2,5-dihydroxymeth

The design and discovery of novel amide CCR5 antagonists

The synthesis of a range of novel amine-containing structures and their primary potency as inhibitors of HIV-1 fusion via blocking of the CCR5 receptor is described. The development of the medicinal chemistry strategy and SAR's which led to the identification of the piperidine amide compounds 33 and 36 as excellent leads for further evaluation is described, along with key physicochemical data which highlighted their lead potential.

CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS

The invention encompasses compounds of formula (I) as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV

Synthesis and antiproliferative properties of N3/8-disubstituted 3,8-diazabicyclo[3.2.1]octane analogues of 3,8-bis[2-(3,4,5-trimethoxyphenyl)pyridin-4-yl]methyl-piperazine

A series of novel N3/8-disubstituted-3,8-diazabicyclo[3.2.1]octanes in order to improve the in vitro activity of the prototype 3,8-bis[2-(3,4,5-trimethoxyphenyl)pyridyl-4-yl)methylpiperazine (1) were synthesized and evaluated by assays of growth inhibition against several tumor cell lines. Compounds 2a,b,f and m demonstrated not only growth-inhibitory activities against leukemia cancer cells, but also fairly good activities against the growth of certain solid tumors. Among them, 2a is the most potent one with IC50 values in the low micromolar range. Moreover, compound 2a has been selected for in vitro testing on MCF-7 cell to evaluate the mode of action of this lead compound.

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

NOVEL SUBSTITUTED DIAZABICYCLO DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS

This invention relates to novel substituted diazabicyclo derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions

3,8-Diazabicyclo[3.2.1]octanes and their use in the treatment of cardiac arrhythmias

There is provided compounds of formula (I), wherein R1, R2 and Ra to Rb have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and v

Tandem cyclisation and [2,3]-Stevens rearrangement to 2-substituted pyrrolidines

Reaction of N-methylallylamine with diethyl meso-2,5-dibromoadipate in DMF at ambient temperature in the presence of potassium carbonate led directly to the two diastereomers of diethyl 2-allyl-N-methylpyrrolidine-2,5-dicarboxylate. The reaction proceeds via a [2,3]-sigmatropic Stevens rearrangement, which occurred spontaneously under the reaction conditions. This gave a higher yield under milder conditions than the traditional Stevens reaction of diethyl N-allylpyrrolidine-2,5-dicarboxylate with iodomethane. The sequence was a key step in the synthesis of a series of analogues of the alkaloid stemofoline.